| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 2.23e-18 | 46 | 95 | 12 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 COL23A1 COL14A1 | 5.35e-12 | 188 | 95 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.31e-07 | 12 | 95 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 SHANK3 COL23A1 MAGI2 COL14A1 BSN | 4.36e-06 | 891 | 95 | 16 | GO:0005198 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 MATN3 COL23A1 ZNF469 ADAMTS7 COL14A1 | 1.25e-08 | 377 | 92 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 MATN3 COL23A1 ZNF469 ADAMTS7 COL14A1 | 1.29e-08 | 378 | 92 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 MATN3 COL23A1 ZNF469 ADAMTS7 COL14A1 | 1.34e-08 | 379 | 92 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 4.74e-08 | 76 | 92 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | synapse assembly | 7.09e-05 | 308 | 92 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL2A1 COL5A1 COL6A1 COL11A1 COL11A2 WIPF1 NCKAP5L SHANK3 RHOU ADAMTS7 RAPGEF3 KANK3 KIF19 COL14A1 | 8.40e-05 | 957 | 92 | 14 | GO:0097435 |
| GeneOntologyBiologicalProcess | cartilage development | 1.08e-04 | 243 | 92 | 7 | GO:0051216 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 1.17e-04 | 4 | 92 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.49e-04 | 343 | 92 | 8 | GO:0061448 | |
| GeneOntologyBiologicalProcess | regulation of snRNA transcription by RNA polymerase II | 1.95e-04 | 5 | 92 | 2 | GO:1905380 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.24e-04 | 569 | 92 | 10 | GO:0034329 | |
| GeneOntologyBiologicalProcess | synapse organization | COL4A1 CC2D1A RPH3A SHANK3 HNRNPK MAGI2 NRXN2 ELFN1 BSN CAPRIN1 SDK1 | 2.34e-04 | 685 | 92 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 3.24e-04 | 133 | 92 | 5 | GO:0002062 | |
| GeneOntologyBiologicalProcess | cell junction organization | COL4A1 TRIP6 CC2D1A IRX3 RPH3A SHANK3 HNRNPK MAGI2 NRXN2 ELFN1 BSN CAPRIN1 SDK1 | 3.75e-04 | 974 | 92 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | tendon development | 4.07e-04 | 7 | 92 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | vocal learning | 4.07e-04 | 7 | 92 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 4.07e-04 | 7 | 92 | 2 | GO:0098596 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 COL25A1 COL23A1 COLEC12 COL14A1 | 2.11e-18 | 88 | 93 | 14 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.03e-12 | 21 | 93 | 7 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.83e-09 | 5 | 93 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 MATN3 COL25A1 COL23A1 ADAMTS7 COL14A1 | 2.68e-09 | 332 | 93 | 13 | GO:0005788 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 COL23A1 COLEC12 ADAMTS7 ELFN1 COL14A1 | 2.98e-08 | 656 | 93 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 COL23A1 COLEC12 ADAMTS7 ELFN1 COL14A1 | 3.11e-08 | 658 | 93 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 COL23A1 COLEC12 COL14A1 | 9.05e-08 | 530 | 93 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.77e-07 | 12 | 93 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.77e-07 | 12 | 93 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | 1.21e-06 | 122 | 93 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | dendrite | FXR2 HCN3 LMTK3 RPH3A SHANK3 HNRNPK MAGI2 ELFN1 IQCJ-SCHIP1 BSN DMWD CAPRIN1 SHISA8 HNRNPR | 2.52e-05 | 858 | 93 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FXR2 HCN3 LMTK3 RPH3A SHANK3 HNRNPK MAGI2 ELFN1 IQCJ-SCHIP1 BSN DMWD CAPRIN1 SHISA8 HNRNPR | 2.59e-05 | 860 | 93 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | anchoring collagen complex | 5.86e-05 | 3 | 93 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | neuron projection terminus | 8.20e-05 | 233 | 93 | 7 | GO:0044306 | |
| GeneOntologyCellularComponent | somatodendritic compartment | FXR2 HCN3 LMTK3 RPH3A SHANK3 HNRNPK MAGI2 ADRA2A RAPGEF3 ELFN1 IQCJ-SCHIP1 BSN DMWD CAPRIN1 SHISA8 HNRNPR | 9.55e-05 | 1228 | 93 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.90e-04 | 6 | 93 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | axon terminus | 3.53e-04 | 210 | 93 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.39e-04 | 8 | 93 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.39e-04 | 8 | 93 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.39e-04 | 8 | 93 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 8.92e-04 | 96 | 93 | 4 | GO:0010494 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.15e-03 | 583 | 93 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | axon | GLDN HCN3 IRX3 LMTK3 HNRNPK ADRA2A RAPGEF3 ELFN1 IQCJ-SCHIP1 BSN HNRNPR | 1.99e-03 | 891 | 93 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL11A1 COL11A2 WIPF1 KIF26A NCKAP5L RADIL KIF19 DYNC1LI2 | 2.25e-03 | 1187 | 93 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | glutamatergic synapse | FXR2 CC2D1A SHANK3 HNRNPK MAGI2 ADRA2A NRXN2 ELFN1 BSN CAPRIN1 | 3.41e-03 | 817 | 93 | 10 | GO:0098978 |
| HumanPheno | Degenerative vitreoretinopathy | 1.83e-06 | 5 | 30 | 3 | HP:0007964 | |
| HumanPheno | Dumbbell-shaped long bone | 6.35e-06 | 7 | 30 | 3 | HP:0000947 | |
| HumanPheno | Abnormality of refraction | COL2A1 COL4A1 COL4A3 COL5A1 COL11A1 COL11A2 KMT2B COL25A1 VSX1 HNRNPK ZNF469 TAF4 CAPRIN1 HNRNPR | 1.51e-05 | 709 | 30 | 14 | HP:0000539 |
| HumanPheno | Abnormal ischium morphology | 1.56e-05 | 27 | 30 | 4 | HP:0003174 | |
| HumanPheno | Cupped ribs | 2.10e-05 | 29 | 30 | 4 | HP:0000887 | |
| HumanPheno | Pain | COL2A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 WIPF1 MATN3 PKDCC EWSR1 VSX1 MAGI2 ZNF469 COL14A1 | 2.35e-05 | 846 | 30 | 15 | HP:0012531 |
| HumanPheno | Osteoarthritis | 3.22e-05 | 65 | 30 | 5 | HP:0002758 | |
| HumanPheno | Heberden's node | 3.35e-05 | 2 | 30 | 2 | HP:0012313 | |
| HumanPheno | Pierre-Robin sequence | 4.01e-05 | 34 | 30 | 4 | HP:0000201 | |
| HumanPheno | Enlarged joints | 5.07e-05 | 13 | 30 | 3 | HP:0003037 | |
| HumanPheno | Hypoplastic ischia | 9.81e-05 | 16 | 30 | 3 | HP:0003175 | |
| HumanPheno | Abnormal palm morphology | COL2A1 COL7A1 COL11A1 COL11A2 KMT2B PKDCC HNRNPK ZNF469 COL14A1 TAF4 HNRNPR | 1.03e-04 | 521 | 30 | 11 | HP:0100871 |
| HumanPheno | Knee pain | 1.19e-04 | 17 | 30 | 3 | HP:0030839 | |
| HumanPheno | Abnormal pubic bone morphology | 1.23e-04 | 45 | 30 | 4 | HP:0003172 | |
| HumanPheno | Arthralgia | 1.51e-04 | 207 | 30 | 7 | HP:0002829 | |
| HumanPheno | Abnormality of the elbow | 1.60e-04 | 282 | 30 | 8 | HP:0009811 | |
| HumanPheno | Hypoplastic pubic bone | 1.96e-04 | 20 | 30 | 3 | HP:0003173 | |
| HumanPheno | short, dumbbell appearance of long bones | 2.00e-04 | 4 | 30 | 2 | HP:0005061 | |
| HumanPheno | Delayed tarsal ossification | 2.00e-04 | 4 | 30 | 2 | HP:0008103 | |
| HumanPheno | Dumbbell-shaped femur | 2.00e-04 | 4 | 30 | 2 | HP:0006375 | |
| HumanPheno | Pretibial blistering | 2.00e-04 | 4 | 30 | 2 | HP:0012221 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 2.00e-04 | 4 | 30 | 2 | HP:0010590 | |
| HumanPheno | Narrow greater sciatic notch | 2.28e-04 | 21 | 30 | 3 | HP:0003375 | |
| HumanPheno | Aplasia/Hypoplasia of the pubic bone | 2.28e-04 | 21 | 30 | 3 | HP:0009104 | |
| HumanPheno | Lumbar hyperlordosis | 2.43e-04 | 99 | 30 | 5 | HP:0002938 | |
| HumanPheno | Vitreoretinopathy | 2.63e-04 | 22 | 30 | 3 | HP:0007773 | |
| HumanPheno | Abnormal greater sciatic notch morphology | 2.63e-04 | 22 | 30 | 3 | HP:0010456 | |
| HumanPheno | Limb pain | 3.11e-04 | 57 | 30 | 4 | HP:0009763 | |
| HumanPheno | Abnormality of tibial epiphyses | 3.32e-04 | 5 | 30 | 2 | HP:0006508 | |
| HumanPheno | Posterior rib cupping | 3.32e-04 | 5 | 30 | 2 | HP:0000922 | |
| HumanPheno | Hypoplasia of the capital femoral epiphysis | 3.43e-04 | 24 | 30 | 3 | HP:0003090 | |
| HumanPheno | Small epiphyses | 3.43e-04 | 24 | 30 | 3 | HP:0010585 | |
| HumanPheno | Aplasia/Hypoplasia of the capital femoral epiphysis | 3.43e-04 | 24 | 30 | 3 | HP:0005003 | |
| HumanPheno | Abnormality of upper limb joint | COL2A1 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN KMT2B MATN3 PKDCC COL25A1 TAF4 | 3.56e-04 | 705 | 30 | 12 | HP:0009810 |
| HumanPheno | Limited elbow movement | 3.62e-04 | 168 | 30 | 6 | HP:0002996 | |
| HumanPheno | Absent epiphyses | 3.89e-04 | 25 | 30 | 3 | HP:0010577 | |
| HumanPheno | Irregular epiphyses | 3.89e-04 | 25 | 30 | 3 | HP:0010582 | |
| HumanPheno | Prominent interphalangeal joints | 4.96e-04 | 6 | 30 | 2 | HP:0006237 | |
| HumanPheno | Enlarged interphalangeal joints | 4.96e-04 | 6 | 30 | 2 | HP:0006247 | |
| HumanPheno | Ankle pain | 4.96e-04 | 6 | 30 | 2 | HP:0030840 | |
| HumanPheno | Arthritis | 4.97e-04 | 251 | 30 | 7 | HP:0001369 | |
| HumanPheno | Retinal detachment | 5.49e-04 | 118 | 30 | 5 | HP:0000541 | |
| HumanPheno | Epiphyseal dysplasia | 6.08e-04 | 29 | 30 | 3 | HP:0002656 | |
| HumanPheno | Abnormal finger morphology | COL2A1 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN KMT2B MATN3 PKDCC COL25A1 SHANK3 HNRNPK ZNF469 TAF4 CAPRIN1 HNRNPR | 6.10e-04 | 1385 | 30 | 17 | HP:0001167 |
| HumanPheno | Abnormal mandible morphology | COL2A1 COL5A1 COL6A1 COL11A1 COL11A2 GLDN KMT2B KIF26A PKDCC COL25A1 SHANK3 HNRNPK TAF4 CAPRIN1 HNRNPR | 6.42e-04 | 1118 | 30 | 15 | HP:0000277 |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 6.44e-04 | 262 | 30 | 7 | HP:0006261 | |
| HumanPheno | Short scapulae | 6.72e-04 | 30 | 30 | 3 | HP:0000906 | |
| HumanPheno | Hypoplastic scapulae | 6.72e-04 | 30 | 30 | 3 | HP:0000882 | |
| HumanPheno | Short distal phalanx of the 5th finger | 6.91e-04 | 7 | 30 | 2 | HP:0004227 | |
| HumanPheno | Lens luxation | 6.91e-04 | 7 | 30 | 2 | HP:0012019 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanx of the 5th finger | 6.91e-04 | 7 | 30 | 2 | HP:0009239 | |
| HumanPheno | Molluscoid pseudotumors | 6.91e-04 | 7 | 30 | 2 | HP:0000993 | |
| HumanPheno | Short femur | 7.41e-04 | 31 | 30 | 3 | HP:0003097 | |
| HumanPheno | Aplasia/Hypoplasia of the scapulae | 7.41e-04 | 31 | 30 | 3 | HP:0006713 | |
| HumanPheno | Myopia | COL2A1 COL4A1 COL4A3 COL5A1 COL11A1 COL11A2 HNRNPK ZNF469 CAPRIN1 | 7.63e-04 | 447 | 30 | 9 | HP:0000545 |
| HumanPheno | Constitutional symptom | COL2A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 KMT2B WIPF1 MATN3 PKDCC EWSR1 VSX1 MAGI2 ZNF469 COL14A1 | 8.09e-04 | 1276 | 30 | 16 | HP:0025142 |
| HumanPheno | Glossoptosis | 8.15e-04 | 32 | 30 | 3 | HP:0000162 | |
| HumanPheno | Aplasia/hypoplasia of the femur | 8.45e-04 | 74 | 30 | 4 | HP:0005613 | |
| HumanPheno | Atypical scarring of skin | 8.45e-04 | 74 | 30 | 4 | HP:0000987 | |
| HumanPheno | Bell-shaped thorax | 8.93e-04 | 33 | 30 | 3 | HP:0001591 | |
| HumanPheno | Abnormal knee morphology | 9.11e-04 | 364 | 30 | 8 | HP:0034669 | |
| HumanPheno | Abnormal femoral neck/head morphology | 9.40e-04 | 201 | 30 | 6 | HP:0003366 | |
| HumanPheno | Abnormality of lower limb joint | COL2A1 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 KMT2B MATN3 PKDCC COL25A1 HNRNPK ZNF469 TAF4 HNRNPR | 9.45e-04 | 1027 | 30 | 14 | HP:0100491 |
| HumanPheno | Limb joint contracture | COL2A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN KMT2B COL25A1 TAF4 | 1.08e-03 | 469 | 30 | 9 | HP:0003121 |
| HumanPheno | Disproportionate short stature | 1.08e-03 | 137 | 30 | 5 | HP:0003498 | |
| HumanPheno | Abnormality of the jaws | COL2A1 COL5A1 COL6A1 COL11A1 COL11A2 GLDN KMT2B KIF26A PKDCC COL25A1 SHANK3 HNRNPK TAF4 CAPRIN1 HNRNPR | 1.12e-03 | 1175 | 30 | 15 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | COL2A1 COL5A1 COL6A1 COL11A1 COL11A2 GLDN KMT2B KIF26A PKDCC COL25A1 SHANK3 HNRNPK TAF4 CAPRIN1 HNRNPR | 1.13e-03 | 1176 | 30 | 15 | HP:0030791 |
| HumanPheno | Hypermetropia | 1.13e-03 | 288 | 30 | 7 | HP:0000540 | |
| HumanPheno | Arthralgia of the hip | 1.18e-03 | 9 | 30 | 2 | HP:0003365 | |
| HumanPheno | Abnormal tarsal ossification | 1.18e-03 | 9 | 30 | 2 | HP:0008369 | |
| HumanPheno | Atrophic scars | 1.25e-03 | 37 | 30 | 3 | HP:0001075 | |
| HumanPheno | Premature osteoarthritis | 1.47e-03 | 10 | 30 | 2 | HP:0003088 | |
| HumanPheno | Schizencephaly | 1.47e-03 | 10 | 30 | 2 | HP:0010636 | |
| HumanPheno | Cigarette-paper scars | 1.47e-03 | 10 | 30 | 2 | HP:0001073 | |
| HumanPheno | Irregular femoral epiphysis | 1.47e-03 | 10 | 30 | 2 | HP:0006361 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 1.48e-03 | 86 | 30 | 4 | HP:0006499 | |
| HumanPheno | Abnormality of the knee | COL2A1 COL5A1 COL6A1 COL7A1 COL11A1 MATN3 PKDCC COL25A1 TAF4 | 1.50e-03 | 491 | 30 | 9 | HP:0002815 |
| HumanPheno | Abnormal joint physiology | COL2A1 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN KMT2B KIF26A MATN3 PKDCC COL25A1 SHANK3 HNRNPK ZNF469 TAF4 | 1.67e-03 | 1358 | 30 | 16 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL2A1 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN KMT2B KIF26A MATN3 PKDCC COL25A1 SHANK3 HNRNPK ZNF469 TAF4 | 1.67e-03 | 1358 | 30 | 16 | HP:0011729 |
| HumanPheno | Tall stature | 1.69e-03 | 225 | 30 | 6 | HP:0000098 | |
| HumanPheno | Lower limb pain | 1.69e-03 | 41 | 30 | 3 | HP:0012514 | |
| Domain | Collagen | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 COL25A1 COL23A1 COLEC12 COL14A1 | 3.65e-18 | 85 | 90 | 14 | IPR008160 |
| Domain | Collagen | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 COL25A1 COL23A1 COLEC12 COL14A1 | 3.65e-18 | 85 | 90 | 14 | PF01391 |
| Domain | Fib_collagen_C | 1.62e-07 | 11 | 90 | 4 | IPR000885 | |
| Domain | COLFI | 1.62e-07 | 11 | 90 | 4 | PF01410 | |
| Domain | NC1_FIB | 1.62e-07 | 11 | 90 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 1.62e-07 | 11 | 90 | 4 | PD002078 | |
| Domain | COLFI | 1.62e-07 | 11 | 90 | 4 | SM00038 | |
| Domain | TSPN | 4.16e-06 | 23 | 90 | 4 | SM00210 | |
| Domain | VWA | 7.31e-06 | 56 | 90 | 5 | PF00092 | |
| Domain | Laminin_G | 8.70e-06 | 58 | 90 | 5 | IPR001791 | |
| Domain | - | 2.88e-05 | 74 | 90 | 5 | 3.40.50.410 | |
| Domain | Laminin_G_2 | 4.04e-05 | 40 | 90 | 4 | PF02210 | |
| Domain | VWFA | 4.73e-05 | 82 | 90 | 5 | PS50234 | |
| Domain | VWA | 5.31e-05 | 84 | 90 | 5 | SM00327 | |
| Domain | LamG | 5.91e-05 | 44 | 90 | 4 | SM00282 | |
| Domain | BAT2_N | 6.87e-05 | 3 | 90 | 2 | PF07001 | |
| Domain | BAT2_N | 6.87e-05 | 3 | 90 | 2 | IPR009738 | |
| Domain | PRRC2 | 6.87e-05 | 3 | 90 | 2 | IPR033184 | |
| Domain | VWF_A | 1.16e-04 | 99 | 90 | 5 | IPR002035 | |
| Domain | C4 | 3.40e-04 | 6 | 90 | 2 | SM00111 | |
| Domain | - | 3.40e-04 | 6 | 90 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 3.40e-04 | 6 | 90 | 2 | IPR001442 | |
| Domain | C4 | 3.40e-04 | 6 | 90 | 2 | PF01413 | |
| Domain | NC1_IV | 3.40e-04 | 6 | 90 | 2 | PS51403 | |
| Domain | - | 1.15e-03 | 95 | 90 | 4 | 2.60.120.200 | |
| Domain | ConA-like_dom | 4.15e-03 | 219 | 90 | 5 | IPR013320 | |
| Domain | PDZ | 4.82e-03 | 141 | 90 | 4 | PF00595 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 2.74e-19 | 41 | 66 | 12 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 7.24e-19 | 44 | 66 | 12 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 5.63e-17 | 61 | 66 | 12 | MM14637 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 1.05e-16 | 64 | 66 | 12 | M26953 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 1.90e-16 | 67 | 66 | 12 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 9.51e-16 | 76 | 66 | 12 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 7.99e-15 | 90 | 66 | 12 | M631 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL14A1 | 2.20e-14 | 50 | 66 | 10 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 | 4.14e-14 | 53 | 66 | 10 | MM14566 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL14A1 | 1.86e-13 | 61 | 66 | 10 | M27103 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL14A1 | 5.90e-13 | 46 | 66 | 9 | M198 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 1.78e-12 | 140 | 66 | 12 | M587 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL14A1 | 5.34e-11 | 74 | 66 | 9 | M160 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 | 1.16e-10 | 114 | 66 | 10 | MM14571 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 COL23A1 COL14A1 | 1.65e-10 | 258 | 66 | 13 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.07e-10 | 20 | 66 | 6 | MM15061 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.91e-10 | 66 | 66 | 8 | M18 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.43e-10 | 42 | 66 | 7 | M7169 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 MATN3 COL25A1 COL23A1 COL14A1 | 1.05e-09 | 300 | 66 | 13 | M610 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.40e-09 | 85 | 66 | 8 | M16441 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.88e-09 | 32 | 66 | 6 | MM14924 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.60e-08 | 63 | 66 | 7 | M11187 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.05e-08 | 38 | 66 | 6 | MM14969 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.03e-08 | 76 | 66 | 7 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.03e-08 | 76 | 66 | 7 | MM14867 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.21e-07 | 84 | 66 | 7 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.51e-07 | 57 | 66 | 6 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.79e-07 | 58 | 66 | 6 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.10e-07 | 59 | 66 | 6 | M27218 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.61e-06 | 19 | 66 | 4 | MM15512 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.54e-06 | 47 | 66 | 5 | MM14925 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.10e-05 | 30 | 66 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.10e-05 | 30 | 66 | 4 | MM15517 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.87e-05 | 199 | 66 | 7 | M7253 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.90e-05 | 41 | 66 | 4 | M27778 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.28e-05 | 15 | 66 | 3 | M27161 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.11e-04 | 261 | 66 | 7 | MM15676 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.69e-04 | 67 | 66 | 4 | MM15345 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.64e-04 | 30 | 66 | 3 | M27216 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.06e-04 | 79 | 66 | 4 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.12e-04 | 418 | 66 | 8 | MM15587 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 9.48e-04 | 10 | 66 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 9.48e-04 | 10 | 66 | 2 | MM1560 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.06e-03 | 43 | 66 | 3 | M39565 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.16e-03 | 11 | 66 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.38e-03 | 12 | 66 | 2 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.63e-03 | 13 | 66 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.63e-03 | 13 | 66 | 2 | M12950 | |
| Pathway | WP_FOCAL_ADHESION | 1.81e-03 | 187 | 66 | 5 | MM15913 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.89e-03 | 14 | 66 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.89e-03 | 14 | 66 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.18e-03 | 15 | 66 | 2 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.15e-03 | 18 | 66 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.15e-03 | 18 | 66 | 2 | MM14882 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.27e-03 | 532 | 66 | 8 | M27870 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.51e-03 | 19 | 66 | 2 | M27221 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.88e-03 | 20 | 66 | 2 | M15394 | |
| Pathway | WP_MRNA_PROCESSING | 5.01e-03 | 451 | 66 | 7 | MM15946 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 5.13e-03 | 23 | 66 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 5.13e-03 | 23 | 66 | 2 | MM1427 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL14A1 | 5.23e-12 | 135 | 97 | 10 | 28675934 |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 5.68e-11 | 4 | 97 | 4 | 17683922 | |
| Pubmed | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL14A1 | 6.92e-11 | 175 | 97 | 10 | 28071719 | |
| Pubmed | COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL6A6 COL25A1 COL23A1 COL14A1 | 5.00e-10 | 153 | 97 | 9 | 25037231 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 21467034 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 8.49e-10 | 6 | 97 | 4 | 8563024 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 17876790 | ||
| Pubmed | 1.22e-09 | 39 | 97 | 6 | 33580754 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 3.95e-09 | 8 | 97 | 4 | 20059976 | |
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 8900172 | ||
| Pubmed | COL2A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 MATN3 COL23A1 | 8.11e-09 | 210 | 97 | 9 | 16537572 | |
| Pubmed | 1.18e-08 | 10 | 97 | 4 | 2446864 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 34009784 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 15141750 | ||
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 36553626 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 2.18e-08 | 62 | 97 | 6 | 28344315 | |
| Pubmed | 2.40e-08 | 167 | 97 | 8 | 22159717 | ||
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 7.58e-08 | 15 | 97 | 4 | 10579729 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.58e-07 | 86 | 97 | 6 | 28327460 | |
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 9409248 | ||
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 19097194 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 20301479 | ||
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 10722718 | ||
| Pubmed | Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality. | 4.18e-07 | 6 | 97 | 3 | 38461417 | |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 15922184 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 4.18e-07 | 6 | 97 | 3 | 3571333 | |
| Pubmed | The molecular chaperone Hsp47 is essential for cartilage and endochondral bone formation. | 4.18e-07 | 6 | 97 | 3 | 22492985 | |
| Pubmed | 5.79e-07 | 24 | 97 | 4 | 25344368 | ||
| Pubmed | 5.84e-07 | 347 | 97 | 9 | 17114649 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 6.73e-07 | 258 | 97 | 8 | 37794589 | |
| Pubmed | 6.87e-07 | 25 | 97 | 4 | 19180518 | ||
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 7.30e-07 | 7 | 97 | 3 | 9334230 | |
| Pubmed | 7.30e-07 | 7 | 97 | 3 | 12847218 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 9.50e-07 | 27 | 97 | 4 | 12192060 | |
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 12183049 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 3997552 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 18816857 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 10382266 | ||
| Pubmed | 1.28e-06 | 29 | 97 | 4 | 22613833 | ||
| Pubmed | 1.93e-06 | 32 | 97 | 4 | 23154389 | ||
| Pubmed | FXR2 HCN3 EWSR1 LMTK3 RPH3A SHANK3 HNRNPK MAGI2 PRRC2C TAF4 BSN CAPRIN1 PRRC2A | 2.83e-06 | 963 | 97 | 13 | 28671696 | |
| Pubmed | 3.90e-06 | 38 | 97 | 4 | 25572963 | ||
| Pubmed | 7.49e-06 | 14 | 97 | 3 | 19542224 | ||
| Pubmed | Hearing Outcomes in Stickler Syndrome: Variation Due to COL2A1 and COL11A1. | 7.70e-06 | 2 | 97 | 2 | 34238052 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34004386 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33348901 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11780999 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22189268 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32756486 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11237662 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30321347 | ||
| Pubmed | Cyclic AMP-Epac signaling pathway contributes to repression of PUMA transcription in melanoma cells. | 7.70e-06 | 2 | 97 | 2 | 28489680 | |
| Pubmed | Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. | 7.70e-06 | 2 | 97 | 2 | 9560475 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 2591970 | ||
| Pubmed | Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1. | 7.70e-06 | 2 | 97 | 2 | 20513134 | |
| Pubmed | Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue. | 7.70e-06 | 2 | 97 | 2 | 18040076 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34680973 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 7560887 | ||
| Pubmed | Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. | 7.70e-06 | 2 | 97 | 2 | 12673280 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30181686 | ||
| Pubmed | Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream. | 7.70e-06 | 2 | 97 | 2 | 11342118 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 7721876 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32427345 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 10486316 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27390512 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24735995 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25240749 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 8.00e-06 | 97 | 97 | 5 | 27559042 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 8.41e-06 | 98 | 97 | 5 | 21942715 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | FXR2 CYP27C1 EWSR1 HNRNPK LENG8 PRRC2C CAPRIN1 PRRC2A HNRNPR | 9.09e-06 | 486 | 97 | 9 | 30940648 |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 9.34e-06 | 15 | 97 | 3 | 9832566 | |
| Pubmed | 1.19e-05 | 50 | 97 | 4 | 23658023 | ||
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 1.39e-05 | 17 | 97 | 3 | 10213384 | |
| Pubmed | TRIP6 FXR2 EWSR1 HNRNPK PRRC2C MEPCE TAF4 CAPRIN1 PRRC2A HNRNPR | 1.51e-05 | 655 | 97 | 10 | 35819319 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX31 FXR2 EWSR1 HNRNPK PRRC2C MEPCE EIF4G3 CAPRIN1 PRRC2A CCDC9 HNRNPR | 1.59e-05 | 807 | 97 | 11 | 22681889 |
| Pubmed | 1.97e-05 | 19 | 97 | 3 | 15689378 | ||
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 2.31e-05 | 3 | 97 | 2 | 19422682 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 14676276 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 3025878 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 2.31e-05 | 3 | 97 | 2 | 34049963 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 17024418 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 34691289 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 3070812 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 27628582 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 15908193 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28059449 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 2.31e-05 | 3 | 97 | 2 | 9582436 | |
| Pubmed | 2.44e-05 | 122 | 97 | 5 | 29530978 | ||
| Pubmed | 2.70e-05 | 21 | 97 | 3 | 27856617 | ||
| Pubmed | 3.18e-05 | 64 | 97 | 4 | 22261194 | ||
| Pubmed | COL4A1 ASB16-AS1 COL5A1 COL6A1 B4GALNT4 FAAP20 NCKAP5L LENG8 RADIL RAPGEF3 ZNF500 COL14A1 EIF4G3 | 3.32e-05 | 1215 | 97 | 13 | 15146197 | |
| Pubmed | 4.10e-05 | 136 | 97 | 5 | 21280222 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 4.60e-05 | 4 | 97 | 2 | 7827955 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 29068597 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 27265029 | ||
| Pubmed | Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | 4.60e-05 | 4 | 97 | 2 | 26966193 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 23624467 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 22814818 | ||
| Pubmed | Mutations in collagen genes resulting in metaphyseal and epiphyseal dysplasias. | 4.60e-05 | 4 | 97 | 2 | 8579897 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 1544908 | ||
| Interaction | MMP9 interactions | 2.65e-08 | 67 | 94 | 7 | int:MMP9 | |
| Interaction | C1QTNF1 interactions | 8.06e-08 | 47 | 94 | 6 | int:C1QTNF1 | |
| Interaction | LAIR2 interactions | 1.04e-07 | 49 | 94 | 6 | int:LAIR2 | |
| Interaction | MMP2 interactions | 1.65e-07 | 87 | 94 | 7 | int:MMP2 | |
| Interaction | PDGFA interactions | 3.61e-07 | 32 | 94 | 5 | int:PDGFA | |
| Interaction | COL8A2 interactions | 1.47e-06 | 42 | 94 | 5 | int:COL8A2 | |
| Interaction | DCN interactions | 1.66e-06 | 43 | 94 | 5 | int:DCN | |
| Interaction | THBS1 interactions | 2.17e-06 | 127 | 94 | 7 | int:THBS1 | |
| Interaction | ATN1 interactions | 2.67e-06 | 187 | 94 | 8 | int:ATN1 | |
| Interaction | MEX3B interactions | 9.43e-06 | 222 | 94 | 8 | int:MEX3B | |
| Interaction | MAG interactions | 9.64e-06 | 29 | 94 | 4 | int:MAG | |
| Interaction | C1QTNF2 interactions | 1.04e-05 | 62 | 94 | 5 | int:C1QTNF2 | |
| Interaction | C1QC interactions | 4.34e-05 | 42 | 94 | 4 | int:C1QC | |
| Interaction | DAZL interactions | 6.05e-05 | 145 | 94 | 6 | int:DAZL | |
| Interaction | YTHDF2 interactions | 1.06e-04 | 312 | 94 | 8 | int:YTHDF2 | |
| Interaction | SNRPEP2 interactions | 1.28e-04 | 4 | 94 | 2 | int:SNRPEP2 | |
| GeneFamily | Collagens | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 2.45e-20 | 46 | 61 | 12 | 490 |
| GeneFamily | PDZ domain containing | 1.73e-03 | 152 | 61 | 4 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 2.08e-03 | 160 | 61 | 4 | 555 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 4.55e-20 | 43 | 97 | 12 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL6A6 COL25A1 COL23A1 COL14A1 | 6.24e-20 | 44 | 97 | 12 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 MATN3 COL25A1 COL23A1 COL14A1 | 1.41e-12 | 270 | 97 | 14 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 MATN3 COL25A1 COL23A1 COL14A1 | 1.81e-12 | 275 | 97 | 14 | M5884 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 6.92e-08 | 29 | 97 | 5 | MM17055 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 MATN3 COL25A1 COL23A1 COLEC12 ADAMTS7 ELFN1 COL14A1 | 1.61e-07 | 1008 | 97 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 GLDN COL6A6 MATN3 COL25A1 COL23A1 COLEC12 ADAMTS7 ELFN1 COL14A1 | 2.06e-07 | 1026 | 97 | 17 | M5889 |
| Coexpression | KANG_AR_TARGETS_UP | 4.04e-07 | 17 | 97 | 4 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 4.04e-07 | 17 | 97 | 4 | M2223 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN | 8.45e-06 | 35 | 97 | 4 | M40938 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN | 9.75e-06 | 200 | 97 | 7 | M7881 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.45e-05 | 40 | 97 | 4 | M5887 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A1 COL5A1 COL6A1 CYP27C1 SHANK3 COLEC12 RAPGEF3 SYDE2 KANK3 COL14A1 | 1.81e-05 | 505 | 97 | 10 | M39167 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 3.40e-05 | 99 | 97 | 5 | M39152 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 3.56e-05 | 50 | 97 | 4 | MM403 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.00e-05 | 352 | 97 | 8 | M17471 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 8.25e-05 | 23 | 97 | 3 | M48001 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 9.05e-05 | 493 | 97 | 9 | M1951 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP | 1.02e-04 | 200 | 97 | 6 | M5273 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.02e-04 | 200 | 97 | 6 | M5930 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 1.07e-04 | 504 | 97 | 9 | MM830 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.42e-04 | 71 | 97 | 4 | M3955 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.66e-04 | 74 | 97 | 4 | M13547 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.47e-04 | 33 | 97 | 3 | M9167 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 2.59e-04 | 83 | 97 | 4 | M2448 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.25e-09 | 177 | 97 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.25e-09 | 177 | 97 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.53e-09 | 191 | 97 | 8 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.19e-08 | 160 | 97 | 7 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-07 | 179 | 97 | 7 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.49e-07 | 182 | 97 | 7 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.55e-07 | 183 | 97 | 7 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.55e-07 | 183 | 97 | 7 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-07 | 189 | 97 | 7 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-07 | 189 | 97 | 7 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-07 | 191 | 97 | 7 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-07 | 191 | 97 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 192 | 97 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 192 | 97 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-07 | 192 | 97 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-07 | 193 | 97 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-07 | 194 | 97 | 7 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-07 | 194 | 97 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-07 | 194 | 97 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 196 | 97 | 7 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 196 | 97 | 7 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.47e-07 | 196 | 97 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-07 | 198 | 97 | 7 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-07 | 198 | 97 | 7 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-07 | 198 | 97 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.73e-07 | 199 | 97 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-07 | 200 | 97 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-07 | 200 | 97 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-07 | 200 | 97 | 7 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.19e-07 | 149 | 97 | 6 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.79e-06 | 167 | 97 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.79e-06 | 167 | 97 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.91e-06 | 169 | 97 | 6 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 169 | 97 | 6 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-06 | 171 | 97 | 6 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.27e-06 | 174 | 97 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.34e-06 | 175 | 97 | 6 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.42e-06 | 176 | 97 | 6 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.58e-06 | 178 | 97 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 179 | 97 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-06 | 179 | 97 | 6 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-06 | 180 | 97 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 180 | 97 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 180 | 97 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-06 | 181 | 97 | 6 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-06 | 181 | 97 | 6 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.94e-06 | 182 | 97 | 6 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 185 | 97 | 6 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 185 | 97 | 6 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 185 | 97 | 6 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 185 | 97 | 6 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 185 | 97 | 6 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-06 | 186 | 97 | 6 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.43e-06 | 187 | 97 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-06 | 188 | 97 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.54e-06 | 188 | 97 | 6 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-06 | 188 | 97 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.54e-06 | 188 | 97 | 6 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-06 | 188 | 97 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.54e-06 | 188 | 97 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.54e-06 | 188 | 97 | 6 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-06 | 189 | 97 | 6 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-06 | 189 | 97 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-06 | 191 | 97 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.88e-06 | 191 | 97 | 6 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-06 | 192 | 97 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-06 | 192 | 97 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.12e-06 | 193 | 97 | 6 | b637e1c47a98009e7d19a6daac78f888fd12748f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.12e-06 | 193 | 97 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.12e-06 | 193 | 97 | 6 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-06 | 193 | 97 | 6 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-06 | 193 | 97 | 6 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 194 | 97 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.24e-06 | 194 | 97 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.24e-06 | 194 | 97 | 6 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.24e-06 | 194 | 97 | 6 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.24e-06 | 194 | 97 | 6 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.24e-06 | 194 | 97 | 6 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-06 | 194 | 97 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.24e-06 | 194 | 97 | 6 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-06 | 195 | 97 | 6 | 598b69032a8441a23749b27863d80f7a1fc82a96 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.37e-06 | 195 | 97 | 6 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 195 | 97 | 6 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-06 | 195 | 97 | 6 | 8aa753934debffe5ae4b5eecb6b50c46d17cc3ec | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 4.50e-06 | 196 | 97 | 6 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-06 | 196 | 97 | 6 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-06 | 196 | 97 | 6 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-06 | 196 | 97 | 6 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 196 | 97 | 6 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.50e-06 | 196 | 97 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.63e-06 | 197 | 97 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.63e-06 | 197 | 97 | 6 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-06 | 197 | 97 | 6 | 467e7cbf511d3bcc701923603032aaf0bba2736d | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.63e-06 | 197 | 97 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-06 | 198 | 97 | 6 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-06 | 198 | 97 | 6 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-06 | 198 | 97 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-06 | 198 | 97 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.77e-06 | 198 | 97 | 6 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| Drug | GK-101 | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.57e-18 | 36 | 97 | 11 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 5.52e-17 | 46 | 97 | 11 | CID000108062 |
| Drug | d-indobufen | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.52e-16 | 50 | 97 | 11 | CID000044562 |
| Drug | ridogrel | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.45e-16 | 52 | 97 | 11 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 3.08e-16 | 53 | 97 | 11 | CID000023340 |
| Drug | AC1LAKND | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.99e-15 | 62 | 97 | 11 | CID000470146 |
| Drug | BAPN | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 9.71e-15 | 71 | 97 | 11 | CID000001647 |
| Drug | malotilate | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 9.71e-15 | 71 | 97 | 11 | CID000004006 |
| Drug | AC1NMZ1B | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.83e-14 | 75 | 97 | 11 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.48e-14 | 77 | 97 | 11 | CID006918182 |
| Drug | halofuginone lactate | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 7.71e-14 | 85 | 97 | 11 | CID000062891 |
| Drug | 4-hydroxyproline | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.67e-13 | 91 | 97 | 11 | CID000000825 |
| Drug | ticlopidine | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 6.77e-13 | 103 | 97 | 11 | CID000005472 |
| Drug | hydroxylysine | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.28e-12 | 109 | 97 | 11 | CID000001029 |
| Drug | AC1L1C2F | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.41e-12 | 110 | 97 | 11 | CID000001711 |
| Drug | foscarnet | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 RPH3A COL23A1 COL14A1 BSN | 1.59e-12 | 190 | 97 | 13 | CID000003414 |
| Drug | PPACK | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.91e-12 | 113 | 97 | 11 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.10e-12 | 114 | 97 | 11 | CID000439300 |
| Drug | Tranilast sodium | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.32e-12 | 115 | 97 | 11 | CID000005527 |
| Drug | Selara | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 5.83e-12 | 125 | 97 | 11 | CID000150310 |
| Drug | DMSe | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.06e-11 | 132 | 97 | 11 | CID000020796 |
| Drug | pirfenidone | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.73e-11 | 138 | 97 | 11 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.87e-11 | 139 | 97 | 11 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.87e-11 | 139 | 97 | 11 | CID000002806 |
| Drug | candesartan cilexetil | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.97e-11 | 145 | 97 | 11 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 9.87e-11 | 162 | 97 | 11 | CID000072363 |
| Drug | khellin | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.77e-10 | 171 | 97 | 11 | CID000003828 |
| Drug | AC1Q6PCP | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 CACNA1I | 2.84e-10 | 230 | 97 | 12 | CID000005267 |
| Drug | AC1L1DD6 | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.88e-10 | 179 | 97 | 11 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 5.15e-10 | 189 | 97 | 11 | CID000001413 |
| Drug | colchine | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 CDAN1 COL14A1 BSN | 9.18e-09 | 383 | 97 | 13 | CID000002833 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 EWSR1 COL25A1 COL23A1 COL14A1 | 9.61e-09 | 314 | 97 | 12 | CID000447989 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 9.72e-09 | 250 | 97 | 11 | CID000000159 |
| Drug | hyaluronan | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.64e-08 | 263 | 97 | 11 | CID000024759 |
| Drug | L-3,4-dehydroproline | 2.65e-08 | 73 | 97 | 7 | CID000094284 | |
| Drug | silibinin | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 3.74e-08 | 285 | 97 | 11 | CID000005213 |
| Drug | AC1L18QD | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.41e-07 | 325 | 97 | 11 | CID000000213 |
| Drug | chondroitin sulfate | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 ADAMTS7 COL14A1 | 1.92e-07 | 413 | 97 | 12 | CID000024766 |
| Drug | losartan | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 6.34e-07 | 378 | 97 | 11 | CID000003961 |
| Drug | AC1L1KMJ | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COLEC12 COL14A1 | 8.67e-07 | 476 | 97 | 12 | CID000030956 |
| Drug | 351A | 1.42e-06 | 20 | 97 | 4 | CID000122144 | |
| Drug | BPAT-143 | 1.49e-06 | 6 | 97 | 3 | CID000146249 | |
| Drug | Y-27632 | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 3.02e-06 | 444 | 97 | 11 | CID000005711 |
| Drug | 4-aminoazobenzene | 9.20e-06 | 66 | 97 | 5 | CID000006051 | |
| Drug | isodesmosine | 1.15e-05 | 33 | 97 | 4 | CID000013811 | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 3737_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.24e-05 | 198 | 97 | 7 | 1241_UP | |
| Drug | aspirin | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 2.79e-05 | 563 | 97 | 11 | CID000002244 |
| Drug | PD123177 | 3.36e-05 | 43 | 97 | 4 | CID000114899 | |
| Drug | NC-4 | 3.69e-05 | 44 | 97 | 4 | CID006420119 | |
| Drug | 1zd2 | 4.03e-05 | 45 | 97 | 4 | CID004149241 | |
| Drug | butylparaben | 5.76e-05 | 157 | 97 | 6 | ctd:C038091 | |
| Drug | pyridinoline | 6.59e-05 | 99 | 97 | 5 | CID000105068 | |
| Drug | desmosine | 7.72e-05 | 53 | 97 | 4 | CID000025435 | |
| Drug | LMWH | COL2A1 COL4A1 COL4A3 COL5A1 COL6A1 COL7A1 COL11A1 COL11A2 COL25A1 COL23A1 COL14A1 | 1.21e-04 | 663 | 97 | 11 | CID000000772 |
| Drug | fullerene C60 | COL2A1 COL5A1 COL7A1 B4GALNT4 KIF26A FXR2 DACT2 PKDCC IRX3 RNF43 SHANK3 COL23A1 ADRA2A RAPGEF3 CACNA1I BSN PRRC2A | 1.83e-04 | 1498 | 97 | 17 | ctd:C069837 |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 1290_DN | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5963_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 3707_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 5637_DN | |
| Drug | enzacamene | 2.29e-04 | 129 | 97 | 5 | ctd:C038939 | |
| Drug | nickel porphinoid | 2.66e-04 | 6 | 97 | 2 | CID006449910 | |
| Disease | Stickler syndrome | 3.22e-07 | 5 | 95 | 3 | cv:C0265253 | |
| Disease | Fibrochondrogenesis | 1.03e-05 | 2 | 95 | 2 | C0265282 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 1.03e-05 | 2 | 95 | 2 | C4520892 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Stickler syndrome, type 3 | 1.03e-05 | 2 | 95 | 2 | C1861481 | |
| Disease | Megaepiphyseal dwarfism | 1.03e-05 | 2 | 95 | 2 | C1855310 | |
| Disease | osteoarthritis (implicated_via_orthology) | 1.43e-05 | 15 | 95 | 3 | DOID:8398 (implicated_via_orthology) | |
| Disease | corneal topography | 2.79e-05 | 109 | 95 | 5 | EFO_0004345 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.02e-05 | 19 | 95 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 3.54e-05 | 20 | 95 | 3 | C0026760 | |
| Disease | Stickler syndrome, type 1 | 1.02e-04 | 5 | 95 | 2 | C2020284 | |
| Disease | Disproportionate short stature | 1.14e-04 | 77 | 95 | 4 | C0878659 | |
| Disease | Cartilage Diseases | 1.53e-04 | 6 | 95 | 2 | C0007302 | |
| Disease | Chondromalacia | 1.53e-04 | 6 | 95 | 2 | C0085700 | |
| Disease | platelet component distribution width | COL4A1 WIPF1 MAGIX HLA-DQB2 EWSR1 HNRNPK RAPGEF3 PRRC2C DLEU7 PRRC2A | 1.62e-04 | 755 | 95 | 10 | EFO_0007984 |
| Disease | carpal tunnel syndrome | 2.00e-04 | 89 | 95 | 4 | EFO_0004143 | |
| Disease | anthropometric measurement | 2.16e-04 | 168 | 95 | 5 | EFO_0004302 | |
| Disease | sphingomyelin measurement | 2.86e-04 | 278 | 95 | 6 | EFO_0010118 | |
| Disease | peptidoglycan recognition protein 1 measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0020624 | |
| Disease | factor VIII measurement, coronary artery disease | 4.96e-04 | 113 | 95 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | apolipoprotein M measurement | 5.54e-04 | 11 | 95 | 2 | EFO_0021945 | |
| Disease | Sensory hearing loss | 5.54e-04 | 11 | 95 | 2 | C1691779 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 5.84e-04 | 118 | 95 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | ferritin measurement | 6.03e-04 | 119 | 95 | 4 | EFO_0004459 | |
| Disease | collagen disease (implicated_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | cleft palate (is_implicated_in) | 6.63e-04 | 12 | 95 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.74e-04 | 53 | 95 | 3 | C4707243 | |
| Disease | diffuse plaque measurement | ONECUT2 COL5A1 ATG9B MATN3 IRX3 ADARB2 MAGI2 C6orf118 COL14A1 | 7.63e-04 | 758 | 95 | 9 | EFO_0010699 |
| Disease | Connective Tissue Diseases | 7.82e-04 | 13 | 95 | 2 | C0009782 | |
| Disease | Tinnitus | 8.40e-04 | 130 | 95 | 4 | HP_0000360 | |
| Disease | C-C motif chemokine 19 measurement | 9.10e-04 | 14 | 95 | 2 | EFO_0008047 | |
| Disease | adverse effect, response to xenobiotic stimulus | 9.22e-04 | 59 | 95 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.20e-03 | 16 | 95 | 2 | C0038015 | |
| Disease | vision disorder | 1.20e-03 | 16 | 95 | 2 | MONDO_0021084 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.20e-03 | 16 | 95 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.20e-03 | 16 | 95 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.20e-03 | 16 | 95 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.20e-03 | 16 | 95 | 2 | C0025237 | |
| Disease | smoking status measurement | KIF26A VSX1 RPH3A MAGI2 COLEC12 C6orf118 NRXN2 ELFN1 IQCJ-SCHIP1 EIF4G3 SDK1 | 1.26e-03 | 1160 | 95 | 11 | EFO_0006527 |
| Disease | keratoconus | 1.28e-03 | 66 | 95 | 3 | MONDO_0015486 | |
| Disease | Hereditary hearing loss and deafness | 1.29e-03 | 146 | 95 | 4 | cv:C0236038 | |
| Disease | thrombomodulin measurement | 1.35e-03 | 17 | 95 | 2 | EFO_0007774 | |
| Disease | Eye Abnormalities | 1.35e-03 | 17 | 95 | 2 | C0015393 | |
| Disease | Van Buchem disease | 1.35e-03 | 17 | 95 | 2 | C0432272 | |
| Disease | HbA1c measurement | 1.53e-03 | 675 | 95 | 8 | EFO_0004541 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.57e-03 | 154 | 95 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Craniofacial Abnormalities | 1.65e-03 | 156 | 95 | 4 | C0376634 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | Osteochondrodysplasias | 1.69e-03 | 19 | 95 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 1.69e-03 | 19 | 95 | 2 | C0013366 | |
| Disease | corneal hysteresis | 1.88e-03 | 20 | 95 | 2 | EFO_0010066 | |
| Disease | neonatal abstinence syndrome | 1.99e-03 | 77 | 95 | 3 | EFO_0005799 | |
| Disease | Cleft Palate | 2.30e-03 | 81 | 95 | 3 | C0008925 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.48e-03 | 23 | 95 | 2 | C0018784 | |
| Disease | response to anticonvulsant | 2.64e-03 | 85 | 95 | 3 | GO_0036277 | |
| Disease | age at menarche | 3.11e-03 | 594 | 95 | 7 | EFO_0004703 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFPPRGPRGSRGNPS | 496 | Q01844 | |
| GRRRDPGPQSNGPGR | 26 | A0A494C0N9 | |
| GRGSRGRGRPARPSP | 321 | Q9Y6R9 | |
| GRGRPARPSPSPTGG | 326 | Q9Y6R9 | |
| GPPRPASGRSQPGRS | 261 | P0C7U0 | |
| PGSPPGGGRAEGPRS | 56 | Q4G0S4 | |
| PRGGGRGSRGPGNPP | 521 | Q96RT6 | |
| RAPPGPRGNPGAQGA | 1176 | Q01955 | |
| GGQLPGARRGPGPRR | 41 | Q96PG8 | |
| GPPGSRRAKGPRQPS | 251 | Q6ZMI3 | |
| GRAPPPRAGASPGSR | 141 | Q495Z4 | |
| SGPRGAPRGRGGPPR | 681 | Q14444 | |
| SRGGEPGPGPLPRSL | 476 | Q09019 | |
| ALPGRPGGPPRGSRG | 81 | Q8IWY9 | |
| PGGPPRGSRGARSQL | 86 | Q8IWY9 | |
| PGAPGPAPGRATEGR | 26 | Q9UKP4 | |
| RGPPGPQGARGFPGT | 266 | P02458 | |
| PPGPRGRSGETGPAG | 1186 | P02458 | |
| GPQGDRGFPGTPGRP | 661 | P02462 | |
| PPRGSPPRGAQPGAG | 741 | Q7Z6P3 | |
| RPPPSGDRARGGAPG | 81 | Q9NS39 | |
| GGRRRQPGQQRPGPG | 31 | Q96DU7 | |
| GRLPSRPPLPGSGGS | 11 | Q9Y570 | |
| RRGRGTLGRPPPGRG | 91 | Q68EN5 | |
| TLGRPPPGRGRNPGG | 96 | Q68EN5 | |
| PPGRGRNPGGGTLRP | 101 | Q68EN5 | |
| PGRQPSRGGSQAGPP | 881 | Q96JH8 | |
| TRGPGGSPGRRPSPA | 41 | O15232 | |
| RSPPTPGTGARGGGR | 46 | P0DP75 | |
| AGARAGPRPGPRPPG | 1406 | Q86UL8 | |
| PRGSRGGRGPSPLAG | 11 | Q9H6Y5 | |
| SRARPRPGGPAPGPN | 991 | Q9HCH0 | |
| LSRRRPRPAGGPSGG | 11 | Q6NZ36 | |
| GGRGRGPPPAPRPTS | 486 | P51116 | |
| RPRNGYQPHRPPGGG | 131 | Q7L2J0 | |
| PARPTQQPGSRRGGG | 641 | Q96JK4 | |
| PPRARPGPGREERGG | 56 | Q6UYE1 | |
| PRRPPPRGSQAAQGG | 171 | Q8N5S9 | |
| HPVGRRNPPPKGRGG | 451 | Q96PV6 | |
| SLGGGPSRRGPLPCP | 656 | Q96Q04 | |
| GPGPGPGPGSTSRRL | 66 | Q9UPA5 | |
| RGPSGSPRTQGRGGP | 386 | O43237 | |
| GGGTRPGPSPVDRRT | 6 | Q8WXQ8 | |
| PGPRGQRGPTGPRGS | 876 | P12107 | |
| GPPGRRGKPGRRGDP | 121 | Q86Y22 | |
| RHRGQKGPRGPPPAG | 251 | P05538 | |
| RGRRGESGPPGQPGP | 131 | Q9BXS0 | |
| LQGPPGPRGPRGDRG | 441 | Q5KU26 | |
| GPRGPRGDRGSQGPP | 446 | Q5KU26 | |
| RGGRGAPPPPRGRGA | 506 | O43390 | |
| PPPRGRAGYSQRGAP | 521 | O43390 | |
| GRGAAGSLRGPPPPP | 71 | O95948 | |
| PRGERGPTGPRGQRG | 836 | P13942 | |
| RDTPGPAGPAGRQPG | 171 | Q9ULI4 | |
| PAGPAGRQPGRAGPD | 176 | Q9ULI4 | |
| PGPGSARGRFPGRPR | 11 | Q9UMN6 | |
| PEASPGPPGPRRGAG | 1036 | Q9UMN6 | |
| PPGGGTRGSLVPTRP | 36 | Q9H8H2 | |
| PPPGGGGRRLGPRGR | 696 | Q9P1Z3 | |
| PPRSPGAPGGARTPG | 276 | Q86Y01 | |
| SAGGPPGRPNGGPRA | 236 | P17483 | |
| SPLAVPPNPGGGSRR | 961 | Q2TAC6 | |
| PPNPGGGSRRATRGP | 966 | Q2TAC6 | |
| SGPGGCPRRPPALAG | 6 | P58401 | |
| PQRGGPSFPRESPRG | 296 | Q5SW24 | |
| GPRGTPGTRGPRGDP | 431 | P12109 | |
| PGTPRPPGASKGGRT | 81 | Q9Y3X0 | |
| PRGPPGPAGPSGESR | 1711 | Q05707 | |
| GPRLPTGSPGAPGRG | 1761 | Q9P0X4 | |
| RGQARPGQRPGPPGG | 111 | F5H4A9 | |
| GPPGPPGRGAAAARQ | 6 | Q6P1N0 | |
| GGPPGRGPPGWRRRE | 161 | Q5T5N4 | |
| PGPRGQRGPTGPRGE | 906 | P20908 | |
| QRGPTGPRGERGPRG | 911 | P20908 | |
| PPPSCRGPGGGRISI | 36 | Q674R7 | |
| PSPGRGVPRSPRGSG | 151 | Q6NY19 | |
| RPGSPGRAGNPGTPG | 1306 | Q02388 | |
| ERAGPGRPRGSPPGR | 21 | Q7Z5N4 | |
| GGGSRNPTPPIGRPT | 161 | O43432 | |
| GRQGRRGWPGPPGTP | 1531 | A6NMZ7 | |
| NPRRSPPGAGGSPPG | 361 | P78415 | |
| APPVPPRGGNGSGRL | 486 | Q75VX8 | |
| GGGRPRQQVSPPRSP | 51 | Q5VT97 | |
| PAGRARPGGGGPQRP | 91 | O00268 | |
| TPGGSRPGPGPAGRF | 296 | Q9Y2J0 | |
| PSPAPGPGRRGGRGE | 41 | Q504Y2 | |
| GPRAPPGRVGLQPSG | 21 | Q6ZQX7 | |
| PPPPGRGGRGGSRAR | 291 | P61978 | |
| GGRDPGGRPSRPSTL | 1351 | Q9Y520 | |
| VGSGGQGPPPPRRES | 906 | P48634 | |
| VPSRRGRGGGRPPPQ | 1166 | P48634 | |
| RRGGPSEPTPGSRPQ | 656 | Q68DV7 | |
| RGSAAPGPPRGPRLQ | 231 | B8ZZ34 | |
| PGPPRGPRLQGGGSL | 236 | B8ZZ34 | |
| PQPAGGRRSGRGPAA | 261 | B3KU38 | |
| SGFPRGPGSGPRPPQ | 86 | E7EW31 | |
| GRAGRGLSGPCRPPP | 21 | Q9UEE5 | |
| PPRPHGRRTGGPQAT | 571 | Q76KP1 | |
| GRRTGGPQATQPRPP | 576 | Q76KP1 | |
| APPGGTERRPNGLGP | 256 | P08913 | |
| SPRSPPPGAQGGGPR | 296 | Q8N5U0 | |
| RRPRGPRGPDPNGLG | 26 | Q86TL0 | |
| APPVPPRRERGGRGG | 16 | Q7L0Q8 | |
| DSRPGRTGPGPAGPG | 26 | Q7RTU0 | |
| ALVPGGSPRGSRPRG | 16 | Q9NZR4 | |
| QGAGPSRPPTPGRNR | 371 | O95398 | |
| RAPQGRAIPRGTPGP | 16 | Q15654 | |
| ASGPGPGAPGPRRPF | 1646 | Q9BYB0 | |
| SGGSRPPLLPPGGRS | 121 | O43516 | |
| PPPRGPGFRGRRGRG | 1076 | Q96JG9 | |
| NPEEPGGSRPGPGRS | 1126 | Q96JG9 | |
| GGSRPGPGRSPQARG | 1131 | Q96JG9 | |
| GPGYPLRGGRAPSPG | 281 | A5D8V6 | |
| PGAPALRSGPSQPRG | 101 | Q8N6K4 | |
| QPRGGPPPGRRASHG | 306 | O60304 | |
| LRGRSGPPPGSQRGP | 81 | Q69YL0 |